Lack of Th2 cytokine increase during spontaneous remission of experimental allergic encephalomyelitis

European Journal of Immunology

Volumn 28, Issue 12, 1998, Pages 3893-3903

  Di Rosa, Francesca ^a   Francesconi, Anna ^a   Di Virgilio, Antonio ^b   Finocchi, Luigi ^a   Santilio, Isabella ^a   Barnaba, Vincenzo ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Pasteur Institute   (Italy)

Author keywords

Autoimmunity; Experimental allergic encephalomyelitis; T cell cytokine

Indexed keywords

CYTOKINE; GAMMA INTERFERON; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE;

EID: 0031769693     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199812)28:12<3893::aid-immu3893>3.0.co;2-%23     Document Type: Article

References (40)

1. Benvenuto, R., Paroli, M., Buttinelli, C., Franco, A., Barnaba, V., Fieschi, C. and Balsano, F., Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis. Clin. Exp. Immunol. 1991. 84: 97-102.
2. Steinman, L., Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996. 85 299-302.
3. Owens, T. and Sriram, S., The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 1995. 13: 51-73.
4. Ben-Nun, A. and Cohen, I. R., Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines. J. Immunol. 1982. 128: 1450-1457.
5. Ellerman, K. E., Powers, J. M. and Brostoff, S. W., A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis. Nature 1988. 331: 265-267.
6. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. and Weiner, H. L., Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994. 265: 1237-1240.
7. Khoury, S. J., Hancock, W. W. and Weiner, H. L., Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 1992. 176: 1355-1364.
8. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B. and Kuchroo, V. K., An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 1995. 3: 397-405.
9. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N. and Glimcher, L. H., B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995. 80: 707-718.
10. Genain, C. P., Abel, K., Belmar, N., Villinger, F, Rosenberg, D. P., Linington, C., Raine, C. S. and Hauser, S. L., Late complications of immune deviation therapy in a nonhuman primate. Science 1996. 274: 2054-2057.
11. Trembleau, S., Penna, G., Gregori, S., Gately, M. K. and Adorini, L., Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 1997. 27: 2330-2339.
12. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997. 389: 737-742.
13. Romagnani, S., Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 1994. 12: 227-257.
14. + suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Immunol. 1992. 22: 1757-1763.
15. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. and Ramshaw, I. A., IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996. 157: 3223-3227.
16. Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L. and Bernard, C. C., TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination, Nature Med. 1998. 4: 78-83.
17. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Rocken, M., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994. 180: 1961-1966.
18. Rott, O., Fleischer, B. and Cash, E., Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994. 24: 1434-1440.
19. Willenborg, D. O., Fordham, S. A., Cowden, W. B. and Ramshaw, I. A., Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 1995. 41: 31-41.
20. Cannella, B., Gao, Y. L., Brosnan, C. and Raine, C. S., IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1996. 45: 735-746.
21. Kennedy, M. K., Torrance, D. S., Picha, K. S. and Mohler, K. M., Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 1992. 149: 2496-2505.
22. Issazadeh, S., Lorentzen, J. C., Mustafa, M. I., Hojeberg, B., Mussener, A. and Olsson, T., Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta. J. Neuroimmunol. 1996. 69: 103-115.
23. Tanuma, N., Kojima, T., Shin, T., Aikawa, Y., Kohji, T., Ishihara, Y. and Matsumoto, Y., Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. J. Neuroimmunol. 1997. 73: 197-206.
24. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T. and Sakoda, S., Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 1995. 62: 103-112.
25. Kuchroo, V. K., Sobel, R. A., Laning, J. C., Martin, C. A., Greenfield, E., Dorf, M. E. and Lees, M. B., Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage. J. Immunol. 1992. 148: 3776-3782.
26. Van Parijs, L. and Abbas, A. K., Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998. 280: 243-248.
27. Sun, D., Qin, Y., Chluba, J., Epplen, J. T. and Wekerle, H., Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature 1988. 332: 843-845.
28. Howell, M. D., Winters, S. T., Olee, T., Powell, H. C., Carlo, D. J. and Brostoff, S. W., Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989. 246: 668-670.
29. Vandenbark, A. A., Chou, Y. K., Whitham, R., Mass, M., Buenafe, A., Liefeld, D., Kavanagh, D., Cooper, S., Hashim, G. A. and Offner, H., Treatment of multiple sclerosis with T cell receptor peptides: results of a double-blind pilot trial. Nature Med. 1996. 2: 1109-1115.
30. McRae, B. L., Kennedy, M. K., Tan, L. J., Dal, C. M., Picha, K. S. and Miller, S. D., Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 1992. 38: 229-240.
31. + T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 1997. 27 2840-2847.
32. Aloisi, F., Penna, G., Cerase, J., Menendez, I. B. and Adorini, L., IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 1997. 159: 1604-1612.
33. Gold, R., Hartung, H. P. and Lassmann, H., T cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci. 1997. 20: 399-404.
34. Allen, S. J., Baker, D., O'Neill, J. K., Davison, A. N. and Turk, J. L., Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cell, Immunol. 1993. 146: 335-350.
35. Guery, J. C., Ria, F., Galbiati, F., Smiroldo, S. and Adorini, L. The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells. Int. Immunol. 1997. 9: 9-15.
36. Matzinger, P., Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994. 12: 991-1045.
37. Lehmann, P. V., Forsthuber, T., Miller, A. and Sercarz, E. E., Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992. 358: 155-157.
38. Wucherpfennig, K. W. and Strominger, J. L., Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995. 80: 695-705.
39. Di Rosa, F. and Barnaba, V., Persisting viruses and chronic inflammation: understanding their relation to autoimmunity. Immunol. Rev. 1998. 164: 17-27.
40. Tuohy, V. K., Lu, Z., Sobel, R. A., Laursen, R. A. and Lees, M. B., Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 1989. 142: 1523-1527.